j

Vasoinhibin reduces joint inflammation, bone loss, and the angiogenesis and vasopermeability of the pannus in murine antigen-induced arthritis




j

Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study




j

The <i>RhHB1</i>/<i>RhLOX4</i> module affects the dehydration tolerance of rose flowers (<i>Rosa hybrida</i>) by fine-tuning jasmonic acid levels




j

npj Genomic Medicine




j

Journal of Perinatology




j

Treating osteoarthritis via gene therapy with rejuvenation factors




j

James F. Scott (1942–2020)




j

HIF1α blockade reduces kidney injury in lupus nephritis




j

A methylation functional detection hepatic cell system validates correlation between DNA methylation and drug-induced liver injury




j

The Pharmacogenomics Journal




j

Shortening jet-lag recovery




j

New journal for reproduction and replication results




j

Worm brain, ocean giant and soothing Jupiter — April’s best science images




j

Journal of Human Hypertension




j

Single-nucleus transcriptomics of the prefrontal cortex in major depressive disorder implicates oligodendrocyte precursor cells and excitatory neurons




j

Why It's So Hard to Junk Bad Decisions—Edging Closer to Understanding “Sunk Cost”

Humans, rats and mice all exhibit the decision-making phenomenon, but new research suggests not all choices are equally vulnerable to it




j

Faculty Positions at the Chinese Institute for Brain Research, Beijing (CIBR)

ABOUT CIBR
The Chinese Institute for Brain Research, Beijing (CIBR) was established in March, 2018 by the Beijing Municipal Government and seven institutions in Beijing. Founded to be a pillar of the China Brain Initiative, CIBR aims to support a vibrant interdisciplinary program in neuroscience and its related disciplines, with both basic and applied research focused ultimately on improving human health. CIBR will also take responsibility for coordinating research institutes and managing …




j

High-level Postdoctoral research fellow recruitment - The international Joint Center for Biomedical Innovation (JCBI), Henan University : Kaifeng, China

The international Joint Center for Biomedical Innovation (JCBI) is comprised of two partner research nodes using nanoparticle technologies to develop solutions for cancer and neurodegenerative diseases diagnostics. Henan University has established a new research laboratory in nano-bio system innovation and theranostics, with start-up funding and new academic positions. Macquarie’s node is built upon its established excellence in neuroscience and cancer research programs. The collaborative succes…




j

Faculty Positions at the Chinese Institute for Brain Research, Beijing (CIBR)

ABOUT CIBR
The Chinese Institute for Brain Research, Beijing (CIBR) was established in March, 2018 by the Beijing Municipal Government and seven institutions in Beijing. Founded to be a pillar of the China Brain Initiative, CIBR aims to support a vibrant interdisciplinary program in neuroscience and its related disciplines, with both basic and applied research focused ultimately on improving human health. CIBR will also take responsibility for coordinating research institutes and managing …




j

Recruitment for director and research principal investigators of Shanghai Key Laboratory of Tissue Engineering Research, at Shanghai Ninth People's Hospital, Shanghai Jiao Tong University

Position
Laboratory director and independent principal investigators

Employer
Shanghai Ninth People’s Hospital affiliated to Shanghai Jiao Tong University School of Medicine

Location
639 Zhi Zao Ju Rd, Huang Pu District, 200011, Shanghai, China

Discipline
Tissue engineering and regenerative medicine related disciplines including: Stem Cell, Developmental Biology, Biomaterials, Biomedical Engineering

Aim:
Shanghai Tissue Engineering Key Laboratory is among the l…




j

Exogenous hormone use, reproductive factors and risk of intrahepatic cholangiocarcinoma among women: results from cohort studies in the Liver Cancer Pooling Project and the UK Biobank




j

British Journal of Cancer




j

Effectiveness of the adjunctive use of ozone and chlorhexidine in patients with chronic periodontitis




j

BDJ Open—4 years on




j

BDJ Open




j

npj Aging and Mechanisms of Disease




j

c-jun N-terminal kinase (JNK); MAP kinase 1 (MAPK1; ERK-2); MAPK3 (ERK-1)

In vitro and rodent studies suggest ophiopogonin D could help prevent doxorubicin-induced cardiotoxicity.




j

Diabetes downregulates peptide transporter 1 in the rat jejunum: possible involvement of cholate-induced FXR activation




j

Correction: Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression




j

Nongjian Tao (1963–2020)




j

Nonoperative treatment of traumatic spinal injuries in Tanzania: who is not undergoing surgery and why?




j

Incidence of acute spinal cord injury in South Korea does not reflect a sizable number of traumatic spinal cord injuries




j

A more accurate incidence of acute spinal cord injury in South Korea can be estimated by the national health insurance system




j

Development of a skin temperature map for dermatomes in individuals with spinal cord injury: a cross-sectional study




j

Recovery after traumatic thoracic- and lumbar spinal cord injury: the neurological level of injury matters




j

Supporting sexual adjustment from the perspective of men living with spinal cord injury




j

Erythrocytosis with <i>JAK2</i> GGCC_46/1 haplotype and without <i>JAK2</i> V617F mutation is associated with <i>CALR</i> rs1049481_G allele




j

British Dental Journal




j

The Folly and Vanity of The Project to Redesign New Delhi, The Wire

Six years ago, the then editor of the Hindustan Times invited me to write a fortnightly column. I agreed, on condition that there would be no censorship. While occasionally some changes to my text were made without my consent, there was no attempt to get me to rewrite my column or change its arguments. Until [...]




j

Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea